LTR 93: AI use cases in MedTech regulatory applications

Summary“To AI or not to AI is no longer a question.”In this Let’s Talk Risk! conversation, Naveen Agarwal and Michelle Wu discuss the transformative role of AI in the regulatory space, particularly in healthcare and life sciences. They explore key trends observed at the JP Morgan Healthcare Conference, share real-world use cases of AI applications, and address concerns about trust, job security, and privacy in the context of AI adoption. Michelle emphasizes that AI is an enabler rather than a replacement, and highlights the importance of adapting workflows to integrate AI effectively. The discussion concludes with key takeaways on leveraging AI for enhanced productivity and strategic decision-making.Listen to the full 30-minute podcast or jump to a section of interest listed below. Chapters00:00 Introducing Michelle Wu of NyquistAI03:00 Key Trends from the JP Morgan Healthcare Conference06:36 AI Use Cases in Regulatory Applications09:59 Trusting AI in Legal Contexts11:49 AI in Product Development, M&A and Growth14:40 AI's Role in Regulatory Intelligence18:25 Addressing Job Security Concerns with AI22:11 AI in IDE and Early Clinical Phase25:40 Managing Privacy Concerns and IP Protection27:05 Managing Risk of Errors from Hallucination and Data Quality28:40 Announcements, Final Thoughts and Key TakeawaysIf you enjoyed this podcast, consider subscribing to the Let’s Talk Risk! newsletter.Suggested links:LTR: AI and the future of work for QA/RA professionals. LTR: A strategic approach to regulatory success with GenAI devices. LTR: How GenAI is transforming Quality in MedTech.Key Takeaways* AI is an enabler, it's not a replacement.* AI will challenge and shake up our traditional way of work.* The best way to adopt AI is to revamp existing workflows.* Trusting AI is a work in progress.* AI can help optimize resources, save time, and reduce costs.* AI can cut down the time for research and decision-making.* We need multilingual professionals who can communicate AI effectively.* AI will not take away jobs, but those who leverage AI will excel.* Data privacy and security are critical in AI applications.* Experimenting with AI solutions can build confidence and skills.KeywordsAI, regulatory applications, healthcare, Nyquist AI, JP Morgan Healthcare Conference, trust in AI, product development, job security, data privacy, risk managementAbout Michelle WuMichelle Wu is the Co-Founder and CEO of NyquistAI, where her team is building the world’s largest AI-empowered data platform for Life Sciences innovators. She has over 10 years of hands-on experience in connecting real-life business needs with the right technical solutions, as well as a deep understanding of the challenges and opportunities in the life science industry. Previously she launched two other startups and also served as a Strategic Planning and BDL Manager at Novartis. Michelle holds a Bachelor’s degree in Foreign Languages with minor in Economics, and an MBA in Healthcare and Investment. Let’s Talk Risk! with Dr. Naveen Agarwal is a weekly live audio event on LinkedIn, where we talk about risk management related topics in a casual, informal way. Join us at 11:00 am EST every Friday on LinkedIn.DisclaimerInformation and insights presented in this podcast are for educational purposes only, and not as legal advice. Views expressed by all speakers are their own and do not reflect those of their respective organizations. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit naveenagarwalphd.substack.com/subscribe